ABCL-612 Real-World Outcomes in Patients With Relapsed or Refractory (r/r) Aggressive Large B-Cell Lymphoma (LBCL) Treated With Chemo-Immunotherapy

Nastoupil, L. J., Andersen, C., Ayers, A., Wang, Y., Habermann, T. M., Chihara, D., Kahl, B. S., Link, B. K., Ayyappan, S., Cohen, J. B., Martin, P., Lossos, I. S., Casulo, C., Lin, R., Li, Z., Larson, M. A., Maurer, M. J., Huynh, L., Gao, C., … Flowers, C. R. (2023). ABCL-612 Real-World Outcomes in Patients With Relapsed or Refractory (r/r) Aggressive Large B-Cell Lymphoma (LBCL) Treated With Chemo-Immunotherapy. Clinical Lymphoma Myeloma and Leukemia, 23, S442–S443. https://doi.org/10.1016/s2152-2650(23)01338-1
Authors:
Loretta J. Nastoupil
Clark R. Andersen
Amy Ayers
Yucai Wang
Thomas M. Habermann
Dai Chihara
Brad S. Kahl
Brian K. Link
Sabarish Ayyappan
Jonathon B. Cohen
Peter Martin
Izidore S. Lossos
Carla Casulo
Ruitao Lin
Ziyi Li
Melissa A. Larson
Matthew J. Maurer
Lynn Huynh
Chi Gao
Ramya Ramasubramanian
Mei Sheng Duh
Alex Mutebi
Tongsheng Wang
Monika Jun
Anthony Wang
Rajesh Kamalakar
Anupama Kalsekar
James R. Cerhan
Christopher R. Flowers
Affiliated Authors:
Ziyi Li
Chi Gao
Subjects:
Lymphoid Neoplasms (OpenAlex Topic)
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1016/s2152-2650(23)01338-1
DOI:
10.1016/s2152-2650(23)01338-1
Journal:
Clinical Lymphoma, Myeloma and Leukemia
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: